早期的生活事件可能是多步骤道路上的第一步,导致肌缩性侧面硬化症
Roger Pamphlett1,2, Jane Parkin Kullmann3
1Department of Neuropathology, Royal Prince Alfred Hospital, Sydney, NSW, Australia. roger.pamphlett@gmail.com.
Scientific reports
|November 18, 2024
概括
早期的环境暴露可能会增加肌缩性侧面硬化症 (ALS) 的风险. 农村生活,年轻的父母和较低的教育程度与ALS发病有关,这表明遗传和环境因素的结合.
科学领域:
- 神经科学是一个神经科学.
- 流行病学 流行病学
- 环境健康 环境健康
背景情况:
- 肌缩侧面硬化症 (ALS) 的发病与遗传和环境因素有关.
- 早期的环境暴露是成人发病的潜在风险因素.
研究的目的:
- 调查早期生活环境暴露与ALS临床发病之间的关联.
- 确定可能导致ALS发展的环境风险因素.
主要方法:
- 进行了国际在线ALS病例控制问卷调查.
- 从1049名40岁或以上的参与者 (568例ALS病例,481例对照) 收集了数据.
- 统计分析比较了ALS患者和对照组之间的环境因素.
主要成果:
- 患有ALS的人更有可能生活在农村地区,父母年轻.
- 较低的教育程度和较少的教育年限与ALS有关.
- 在兄弟姐妹数量,出生顺序,成年人身高,出生体重,父母吸烟,剖腹产或吸烟开始年龄方面没有发现显著差异.
结论:
- 早期的生活环境条件可能充当多环境风险因素,与多遗传变异相互作用,引发ALS发病.
- 减少对早期不利的环境因素的暴露可能会降低患ALS的风险.
- 对特定环境暴露的进一步研究是有必要的.
相关概念视频
Cross-bridge Cycle
116.9K
As muscle contracts, the overlap between the thin and thick filaments increases, decreasing the length of the sarcomere—the contractile unit of the muscle—using energy in the form of ATP. At the molecular level, this is a cyclic, multistep process that involves binding and hydrolysis of ATP, and movement of actin by myosin.
116.9K
Parkinson's Disease: Overview
482
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
482
Amyloid Fibrils
9.3K
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
9.3K
Alzheimer's Disease: Overview
448
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
448


